Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T1 hypointensities and axonal loss.

F Barkhof1, G B Karas, M A van Walderveen

  • 1Department of Radiology, Multiple Sclerosis MRI Research Centre Amsterdam, Vrije Universiteit Hospital, 1007 MB Amsterdam, The Netherlands. F.Barkhof@AZVU.NL

Neuroimaging Clinics of North America
|May 22, 2001
PubMed
Summary

T1 hypointensities, markers of tissue damage in progressive multiple sclerosis, better predict disability than T2 lesions. These findings support their use as outcome measures in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease.

Alzheimer's research & therapy·2026
Same author

Aging does not affect the relationship between OCT and clinical or MRI outcome measures.

Multiple sclerosis and related disorders·2026
Same author

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Journal of neurology·2025
Same author

Repeatability and reproducibility of brain age estimates in multiple sclerosis for three publicly available models.

Neuroimage. Reports·2025
Same author

Clinical phenotypes of Alzheimer's disease: investigating atrophy patterns and their pathological correlates.

Alzheimer's research & therapy·2025
Same author

Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer's Disease Trials.

The journal of prevention of Alzheimer's disease·2024

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • T1 hypointensities are identified on T1-weighted MRI sequences.
  • These lesions indicate tissue damage, including matrix destruction and axonal loss.

Purpose of the Study:

  • To highlight the significance of T1 hypointensities in multiple sclerosis.
  • To establish T1 hypointensities as reliable markers for clinical disability and treatment efficacy.

Main Methods:

  • Analysis of T1-weighted conventional spin-echo sequences.
  • Correlation of T1 hypointensities with clinical disability assessments.

Main Results:

  • T1 hypointensities are markers of matrix destruction and axonal loss.
  • T1 hypointensities show a stronger correlation with clinical disability compared to T2-weighted images.

Related Experiment Videos

  • These lesions are prevalent in patients with progressive multiple sclerosis.

    • Conclusions:

    • T1 hypointensities are valuable imaging biomarkers in multiple sclerosis.
    • Their ability to predict clinical disability supports their use as surrogate outcome measures in clinical trials for progressive multiple sclerosis.